DMPK
Myotonic Dystrophy: DMPK Trinucleotide Repeat Analysis
Key Information
Lab:
TAT:
21 days
Price:
$350
CPT Code(s):
81234
Test Code:
DMYO
Prenatal Samples Accepted
Myotonic Dystrophy: DMPK Trinucleotide Repeat Analysis
DMPK trinucleotide repeat analysis is a molecular test used to identify expanded CTG repeats in the gene associated with myotonic dystrophy. This test can also identify disease-causing variants within a family to facilitate carrier screening.
Myotonic dystrophy
Clinical Information
Myotonic dystrophy is the most common form of adult onset muscular dystrophy and has an incidence of 1/8000 individuals. This autosomal dominant disorder is characterized by myotonia, muscle wasting, frontal balding, hypogonadism, and ocular and ECG abnormalities. Genetic anticipation is commonly seen in families with myotonic dystrophy. In these families, extreme amplification can occur during mother to child transmission of the abnormal allele leading to a congenital form of the disease. Congenital myotonic dystrophy can be associated with a very severe disease state including generalized hypotonia and intellectual disability.
Technical Information
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis is available if the fetus is at risk of inheriting a DMPK repeat expansion. Testing can be performed on cultured CVS, direct amniotic fluid (if DNA requirements are met), or cultured amniocytes. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
